DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Sage - 1 ” - 1 Matthew Kacsmaryk - 1 “ - 1 Kacsmaryk - 1 ” Sage - 1 Dr - 1 Sanjay Gupta - 1
Top related locs:
Texas Florida “ mifepristone Charlotte WILMINGTON , Delaware California North Dakota
Top related orgs:
Charlotte Lozier Institute - 2 American Association of Pro - 2 CNN - 1 Sage Publications - 1 Health Services Research - 1 Chemical - 1 US - 1 Elliot Institute - 1

Search resuls for: "American Association of Pro"


3 mentions found


☆ Journal publisher retracts studies used by Texas judge who ruled to suspend use of abortion pill
  + stars: | 2024-02-07 | by ( Jen Christensen | ) edition.cnn.com   time to read: +6 min
CNN —The academic publisher Sage Publications has retracted studies used by a Texas judge in a ruling that would suspend federal approval of the abortion pill mifepristone. The 2021 study concluded that ER visits were more likely after a medication abortion rather than a surgical abortion. Kacsmaryk cited this study to suggest that the number of adverse events from medication abortion drugs is probably under-reported. The US Supreme Court will hear arguments in March about mifepristone, one of two drugs commonly used in the US for a medication abortion. Medication abortion is the most common form of abortion in the US, and multiple peer-reviewed studies have shown that it is highly safe and effective.
Persons: Sage, ”, Matthew Kacsmaryk, “, Kacsmaryk, ” Sage, Dr, Sanjay Gupta, Jim Studnicki, Studnicki Organizations: CNN, Sage Publications, Health Services Research, Chemical, US, Charlotte Lozier Institute, Elliot Institute, American Association of Pro, CNN Health Locations: Texas, “, Florida, mifepristone, Charlotte
☆ Five doctors backing the US legal case against the abortion pill
  + stars: | 2023-06-29 | by ( Tom Hals | Thomson Reuters | Tom Hals Is An Award-Winning Reporter With Years Of Experience Working In Asia | ) www.reuters.com   time to read: +3 min
WILMINGTON, Delaware, June 29 (Reuters) - A legal case making its way through the courts could remove the abortion pill mifepristone from the market or restrict access to the drug. George Delgado - A California palliative care specialist, Delgado helped pioneer "abortion reversal" treatments for women who change their mind after taking mifepristone. Circuit Court of Appeals as an example of the harm caused by the approval of the abortion pill. The American College of Obstetrics and Gynecologists has said abortion reversal is not supported by science and does not meet clinical standards. Foley said in his abortion pill testimony he also treats women for abortion pill reversal.
Persons: George Delgado, Delgado, mifepristone, Gynecologists, Ingrid Skop, Skop, Donna Harrison, Harrison, Tyler Johnson, Johnson, AAPLOG, Steven Foley, Foley, CMDA, Tom Hals, Rosalba O'Brien Organizations: U.S, Circuit, Appeals, American, of Obstetrics, American Association of Pro, Christian Medical, Dental, Charlotte Lozier Institute, Reuters, Indiana, Alliance, Hippocratic, Republican, FDA, Thomson Locations: WILMINGTON , Delaware, California, Texas, Florida, North Dakota, An Indiana, Indiana, Wilmington , Delaware
☆ Reversing abortion drug's approval would harm public interest, U.S. FDA says
  + stars: | 2023-01-17 | by ( Brendan Pierson | Thomson Reuters | Brendan Pierson Reports On Product Liability Litigation | ) www.reuters.com   time to read: +3 min
Medication abortion has drawn increasing attention since the U.S. Supreme Court last June overturned its landmark 1973 Roe v. Wade decision that had legalized abortion nationwide. Nearly all abortions, including medication abortions, are now banned in 12 states, and 16 states that permit some abortions also had laws restricting medication abortion as of November, according to the Guttmacher Institute, a research group that supports abortion rights. "The FDA, by approving chemical abortion drugs for home use, puts a woman or girl's life at risk." In its court filing, the FDA said there was no basis for second-guessing the FDA's judgment. The FDA said that pulling the drug would force patients seeking abortions in many cases to undergo unnecessary and more invasive surgical abortion.
0 next >>
Total: 3